Your browser doesn't support javascript.
loading
Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate Cancer.
Zhang, Wei; Liu, Bo; Wu, Wenhui; Li, Likun; Broom, Bradley M; Basourakos, Spyridon P; Korentzelos, Dimitrios; Luan, Yang; Wang, Jianxiang; Yang, Guang; Park, Sanghee; Azad, Abul Kalam; Cao, Xuhong; Kim, Jeri; Corn, Paul G; Logothetis, Christopher J; Aparicio, Ana M; Chinnaiyan, Arul M; Navone, Nora; Troncoso, Patricia; Thompson, Timothy C.
Afiliação
  • Zhang W; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Liu B; Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai, China.
  • Wu W; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Li L; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Broom BM; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Basourakos SP; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Korentzelos D; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Luan Y; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Yang G; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Park S; Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Azad AK; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Cao X; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kim J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Corn PG; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Logothetis CJ; Michigan Center for Translational Pathology, Howard Hughes Medical Institute, Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan.
  • Aparicio AM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chinnaiyan AM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Navone N; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Troncoso P; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Thompson TC; Michigan Center for Translational Pathology, Howard Hughes Medical Institute, Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan.
Clin Cancer Res ; 24(3): 696-707, 2018 02 01.
Article em En | MEDLINE | ID: mdl-29138344

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Prostata Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Dano ao DNA / Transdução de Sinais / Poli(ADP-Ribose) Polimerases / Carcinoma Neuroendócrino / Proteína Proto-Oncogênica N-Myc Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Prostata Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Dano ao DNA / Transdução de Sinais / Poli(ADP-Ribose) Polimerases / Carcinoma Neuroendócrino / Proteína Proto-Oncogênica N-Myc Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article